Effect of Steady-State Faldaprevir on the Pharmacokinetics of Steady-State Methadone and Buprenorphine-Naloxone in Subjects Receiving Stable Addiction Management Therapy

Por Joseph, David, Schobelock, Michael J., Riesenberg, Robert R., Vince, Bradley D., Webster, Lynn R., Adeniji, Abidemi, Elgadi, Mabrouk, Huang, Fenglei
Publicado no Antimicrob Agents Chemother (2014)

Sustained-Release Buprenorphine (RBP-6000) Blocks the Effects of Opioid Challenge With Hydromorphone in Subjects With Opioid Use Disorder

Por Nasser, Azmi F., Greenwald, Mark K., Vince, Bradley, Fudala, Paul J., Twumasi-Ankrah, Philip, Liu, Yongzhen, Jones, JP, Heidbreder, Christian
Publicado no J Clin Psychopharmacol (2016)

Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder: A Randomized Clinical Trial

Por Walsh, Sharon L., Comer, Sandra D., Lofwall, Michelle R., Vince, Bradley, Levy-Cooperman, Naama, Kelsh, Debra, Coe, Marion A., Jones, Jermaine D., Nuzzo, Paul A., Tiberg, Fredrik, Sheldon, Behshad, Kim, Sonnie
Publicado no JAMA Psychiatry (2017)